Gonadotrophins for ovulation induction in women with polycystic ovary syndrome-Reference-Cited by-同舟云学术

Gonadotrophins for ovulation induction in women with polycystic ovary syndrome

Published:2019-01-16 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Weiss Nienke S¹,Kostova Elena²,Nahuis Marleen³,Mol Ben Willem J⁴,van der Veen Fulco⁵,van Wely Madelon²

Affiliation:

1. Amsterdam UMC, Free Medical University; Center for Reproductive Medicine; De Boelelaan 1105 Amsterdam Netherlands 1081 HV

2. Amsterdam UMC, University of Amsterdam; Center for Reproductive Medicine; Meibergdreef 9 Amsterdam Netherlands 1105 AZ

3. VU University Medical Center; Amsterdam Netherlands

4. Monash University; Department of Obstetrics and Gynaecology; 246 Clayton Road Clayton Victoria Australia 3168

5. Amsterdan UMC, University of Amsterdam; Center for Reproductive Medicine; Meibergdreef 9 Amsterdam Netherlands 1105 AZ

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010290.pub3/epdf/full

Reference60 articles.

1. Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial;Balen;Human Reproduction,2007

2. Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene-resistant, normogonadotropic, chronic anovulation; a prospective, multicenter, assessor-blind, randomized, clinical trial;Coelingh Bennink;Fertility and Sterility,1998

3. A new highly purified human-derived FSH, Bravelle, is as effective and well tolerated as recombinant follitropin beta in ovulation induction in infertile women with ovulatory dysfunction;Feigenbaum;Today's Therapeutic Trends,2001

4. Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease;Gadir;Clinical Endocrinology,1990

5. Ovulation induction with urinary FSH or recombinant FSH in polycystic ovary syndrome patients: a prospective randomized analysis of cost-effectiveness;Gerli;Reproductive BioMedicine Online,2004

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prise en charge de première intention du couple infertile : mise à jour des RPC 2010 du CNGOF;Gynécologie Obstétrique Fertilité & Sénologie ;2024-05

2. Les médicaments associés à l’assistance médicale à la procréation;Actualités Pharmaceutiques;2024-03

3. Effects of different gonadotropin preparations in GnRH antagonist protocol for patients with polycystic ovary syndrome during IVF/ICSI: a retrospective cohort study;Frontiers in Endocrinology;2024-02-12

4. Nonlinear relationship between gonadotropin total dose applied and live birth rates in non-PCOS patients: a retrospective cohort study;Scientific Reports;2024-01-17

5. A Complete Overview of the Polycystic Ovarian Syndrome with Recent Advancement in Clinical Trial;Current Women s Health Reviews;2024-01-16